Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shervin Assassi

Showing results (111-120 of 238) with videos related to

Pageof 24
Sort By:
Clinical and Experimental Rheumatology|July 1, 2017
Design of a randomised, placebo-controlled clinical trial of nintedanib in patients with systemic sclerosis-associated interstitial lung disease (SENSCIS™)Oliver Distler, Kevin K Brown, Jörg H W Distler, et al.
Annals of the Rheumatic Diseases|August 8, 2020
Safety and tolerability of nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from the SENSCIS trialJames R Seibold, Toby M Maher, Kristin B Highland, et al.
Arthritis Care & Research|October 16, 2025
Assessment of Skin in Patients With Systemic Sclerosis Using High-Frequency Ultrasound and Shear Wave Elastography: A Comparative Study With Histology, Molecular, and Clinical ParametersRuhani Desai, Filemon Tan, Minghua Wu, et al.
Arthritis and Rheumatism|February 1, 2011
HLA-DRB1*0407 and *1304 are risk factors for scleroderma renal crisisBinh Nguyen, Maureen D Mayes, Frank C Arnett, et al.
Arthritis and Rheumatism|December 2, 2009
Polymorphisms in TBX21 and STAT4 increase the risk of systemic sclerosis: evidence of possible gene-gene interaction and alterations in Th1/Th2 cytokinesPravitt Gourh, Sandeep K Agarwal, Dipal Divecha, et al.
Clinical and Experimental Rheumatology|August 6, 2013
Treatment of early diffuse systemic sclerosis skin diseaseTracy M Frech, Victoria K Shanmugam, Ami A Shah, et al.
Rheumatology (Oxford, England)|November 19, 2013
Cardiac arrhythmias and conduction defects in systemic sclerosisAlessandra Vacca, Christophe Meune, Jessica Gordon, et al.
Frontiers in Genetics|June 27, 2022
Contribution of HLA and KIR Alleles to Systemic Sclerosis Susceptibility and Immunological and Clinical Disease SubtypesAimee L Hanson, Joanne Sahhar, Gene-Siew Ngian, et al.
Medrxiv : the Preprint Server for Health Sciences|December 18, 2025
Early gastrointestinal manifestations predict outcomes in patients with systemic sclerosisAli Y Ayla, Ashish P Balar, Ernesto Calderon Martinez, et al.
Rheumatology (Oxford, England)|May 17, 2026
Early gastrointestinal manifestations predict disease progression and mortality in patients with systemic sclerosisAli Y Ayla, Ashish P Balar, Ernesto Calderon Martinez, et al.
Pageof 24

Showing results (111-120 of 238) with videos related to

Sort By:
Pageof 24
Clinical and Experimental Rheumatology|July 1, 2017
Design of a randomised, placebo-controlled clinical trial of nintedanib in patients with systemic sclerosis-associated interstitial lung disease (SENSCIS™)Oliver Distler, Kevin K Brown, Jörg H W Distler, et al.
Annals of the Rheumatic Diseases|August 8, 2020
Safety and tolerability of nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from the SENSCIS trialJames R Seibold, Toby M Maher, Kristin B Highland, et al.
Arthritis Care & Research|October 16, 2025
Assessment of Skin in Patients With Systemic Sclerosis Using High-Frequency Ultrasound and Shear Wave Elastography: A Comparative Study With Histology, Molecular, and Clinical ParametersRuhani Desai, Filemon Tan, Minghua Wu, et al.
Arthritis and Rheumatism|February 1, 2011
HLA-DRB1*0407 and *1304 are risk factors for scleroderma renal crisisBinh Nguyen, Maureen D Mayes, Frank C Arnett, et al.
Arthritis and Rheumatism|December 2, 2009
Polymorphisms in TBX21 and STAT4 increase the risk of systemic sclerosis: evidence of possible gene-gene interaction and alterations in Th1/Th2 cytokinesPravitt Gourh, Sandeep K Agarwal, Dipal Divecha, et al.
Clinical and Experimental Rheumatology|August 6, 2013
Treatment of early diffuse systemic sclerosis skin diseaseTracy M Frech, Victoria K Shanmugam, Ami A Shah, et al.
Rheumatology (Oxford, England)|November 19, 2013
Cardiac arrhythmias and conduction defects in systemic sclerosisAlessandra Vacca, Christophe Meune, Jessica Gordon, et al.
Frontiers in Genetics|June 27, 2022
Contribution of HLA and KIR Alleles to Systemic Sclerosis Susceptibility and Immunological and Clinical Disease SubtypesAimee L Hanson, Joanne Sahhar, Gene-Siew Ngian, et al.
Medrxiv : the Preprint Server for Health Sciences|December 18, 2025
Early gastrointestinal manifestations predict outcomes in patients with systemic sclerosisAli Y Ayla, Ashish P Balar, Ernesto Calderon Martinez, et al.
Rheumatology (Oxford, England)|May 17, 2026
Early gastrointestinal manifestations predict disease progression and mortality in patients with systemic sclerosisAli Y Ayla, Ashish P Balar, Ernesto Calderon Martinez, et al.
Pageof 24